全文获取类型
收费全文 | 580篇 |
免费 | 19篇 |
专业分类
599篇 |
出版年
2016年 | 6篇 |
2015年 | 16篇 |
2014年 | 18篇 |
2013年 | 26篇 |
2012年 | 16篇 |
2011年 | 20篇 |
2010年 | 27篇 |
2009年 | 28篇 |
2008年 | 14篇 |
2007年 | 16篇 |
2006年 | 13篇 |
2005年 | 16篇 |
2004年 | 15篇 |
2001年 | 7篇 |
2000年 | 7篇 |
1999年 | 7篇 |
1998年 | 13篇 |
1997年 | 12篇 |
1996年 | 9篇 |
1995年 | 12篇 |
1994年 | 7篇 |
1993年 | 9篇 |
1992年 | 6篇 |
1991年 | 7篇 |
1989年 | 9篇 |
1988年 | 15篇 |
1987年 | 7篇 |
1985年 | 6篇 |
1984年 | 11篇 |
1983年 | 7篇 |
1982年 | 18篇 |
1981年 | 6篇 |
1980年 | 5篇 |
1979年 | 8篇 |
1978年 | 6篇 |
1977年 | 9篇 |
1976年 | 7篇 |
1975年 | 8篇 |
1974年 | 7篇 |
1973年 | 6篇 |
1972年 | 10篇 |
1959年 | 9篇 |
1958年 | 11篇 |
1957年 | 5篇 |
1955年 | 7篇 |
1954年 | 7篇 |
1953年 | 10篇 |
1952年 | 6篇 |
1951年 | 8篇 |
1950年 | 6篇 |
排序方式: 共有599条查询结果,搜索用时 9 毫秒
501.
Central processing of inertial sensory information about head attitude and motion in space is crucial for motor control. Vestibular signals are coded relative to a non-inertial system, the head, that is virtually continuously in motion. Evidence for transformation of vestibular signals from head-fixed sensory coordinates to gravity-centered coordinates have been provided by studies of the vestibulo-ocular reflex. The underlying central processing depends on otolith afferent information that needs to be resolved in terms of head translation related inertial forces and head attitude dependent pull of gravity. Theoretical solutions have been suggested, but experimental evidence is still scarce. It appears, along these lines, that gaze control systems are intimately linked to motor control of head attitude and posture. 相似文献
502.
Deuterostome phylogeny and the sister group of the chordates: evidence from molecules and morphology 总被引:13,自引:3,他引:10
Complete coding regions of the 18S rRNA gene of an enteropneust
hemichordate and an echinoid and ophiuroid echinoderm were obtained and
aligned with 18S rRNA gene sequences of all major chordate clades and four
outgroups. Gene sequences were analyzed to test morphological character
phylogenies and to assess the strength of the signal. Maximum- parsimony
analysis of the sequences fails to support a monophyletic Chordata; the
urochordates form the sister taxon to the hemichordates, and together this
clade plus the echinoderms forms the sister taxon to the cephalochordates
plus craniates. Decay, bootstrap, and tree-length distribution analyses
suggest that the signal for inference of dueterostome phylogeny is weak in
this molecule. Parsimony analysis of morphological plus molecular
characters supports both monophyly of echinoderms plus enteropneust
hemichordates and a sister group relationship of this clade to chordates.
Evolutionary parsimony does not support chordate monophyly.
Neighbor-joining, Fitch-Margoliash, and maximum-likelihood analyses support
a chordate lineage that is the sister group to an
echinoderm-plus-hemichordate lineage. The results illustrate both the
limitations of the 18S rRNA molecule alone for high- level phylogeny
inference and the importance of considering both molecular and
morphological data in phylogeny reconstruction.
相似文献
503.
504.
A spore-clock for studying the hourly rate ofspore discharge over a 24-hour period is described. A numberof the experiments reported in this paper have involved theuse of this apparatus. In Sordaria fimicola there is a distinct positive light-dischargereaction in a dark-conditioned culture, the rate of spore dischargeincreasing steeply to a peak 23 hours after brief stimulationby bright light. Although darkening a light-conditioned cultureleads to an immediate decrease in the rate of discharge, thereis no evidence of a delayed negative dark-discharge reaction. In S. verruculosa with a 12-hours light: 12-hours dark dailyreëgime, more spores are discharged in the dark than inthe light periods if the intensity of illumination is low. Withhigher light intensity there is no significant difference betweenthe number of spores discharged in light and dark periods. Asin S. fimicola there is a positive light-discharge reaction,the interval between stimulus and maximum response being muchlonger (812 hours). When a dark-conditioned culture istransferred to light for 48 hours and then returned to darknessfor a further 48 hours it is apparent that not only is therea positive light-discharge reaction but also a negative dark-dischargeresponse. The plateau level of discharge is essentiallythe same in light and darkness. It is confirmed that in Hypoxylon fuscum light inhibits discharge. 相似文献
505.
Abstract. A pheromone sprayer and an electroantennogram (EAG) are used to study sensory adaptation in the antennae of male obliquebanded leafrollers, Choristoneura rosaceana and oriental fruit moths, Grapholita molesta , to the main pheromone compounds ( Z )-11-tetradecen-1-yl acetate ( Z 11-14:Ac) and ( Z )-8-dodecen-1-yl acetate ( Z 8-12:Ac), respectively. The atomization of 0.125, 0.25, 0.5 or 1 μL ethanol min−1 into the EAG air delivery tube at an airflow rate of 2 L min−1 , with resultant concentrations of 6.25, 12.5, 25 or 50 × 10−5 μL ethanol mL air−1 , respectively, does not affect the EAG response of C. rosaceana or C. molesta after a 30-min exposure period. The atomization of 0.125 μL min−1 of a solution of 8 mg Z 11-14:Ac mL−1 ethanol into the EAG air delivery tube at an airflow rate of 2 L min−1 , with a resultant concentration of 0.5 ng pheromone mL−1 air, reduces the EAG response of C. rosaceana by approximately 70% after a 15-min exposure period. An additional 15 min of exposure to pheromone does not result in increased sensory adaptation. Antennae recover 32% of the lost responsiveness when exposed to pheromone-free air for 15 min. The atomization of 0.125 μL min−1 of a solution of 8 mg Z 8-12:Ac mL−1 ethanol into the EAG air delivery tube at an airflow rate of 2 L min−1 , with a resultant concentration of 0.5 ng pheromone mL−1 air, reduces the EAG response of C. molesta antenna by approximately 80% after a 15- or 30-min exposure period. The antennae of this species do not recover responsiveness when exposed to pheromone-free air for 15 min. 相似文献
506.
Philippe GAC Vanden Bergh Thomas Fett Laurent LM Zecchinon Anne VT Thomas Daniel JM Desmecht 《BMC veterinary research》2005,1(1):1-7
Background
Lymphocyte function-associated antigen-1 (LFA-1, CD11a/CD18, alphaLbeta2), the most abundant and widely expressed beta2-integrin, is required for many cellular adhesive interactions during the immune response. Many studies have shown that LFA-1 is centrally involved in the pathogenesis of several diseases caused by Repeats-in-toxin (RTX) -producing bacteria. 相似文献507.
Sub-cellular localization of Ni in the hyperaccumulator, Hybanthus floribundus (Lindley) F. Muell 总被引:3,自引:0,他引:3
S. D. BIDWELL S. A. CRAWFORD I. E. WOODROW J. SOMMER-KNUDSEN & A. T. MARSHALL 《Plant, cell & environment》2004,27(6):705-716
The cellular and subcellular distribution of Ni within leaves of Hybanthus floribundus (Lindley) F. Muell, a hyperaccumulator of Ni, was investigated at relatively high spatial resolution using energy‐dispersive X‐ray microanalysis (EDAX). Elemental distribution maps showed that Ni was predominantly localized in the vacuoles of epidermal cells in the leaves. Quantification of Ni revealed concentrations up to 275 mmol kg?1 (embedded tissue) in some epidermal vacuoles. The accumulation of Ni in these cells was associated with a decrease in the concentration of Na and K. There was no indication that Ni was associated with P, S or Cl in the vacuoles. Ni was also concentrated on the outside of cell walls throughout the leaves, indicating that apoplastic compartmentation is also involved in Ni tolerance and accumulation in this plant. 相似文献
508.
Rieke Alten Hermann Gram Leo A Joosten Bvanden Wim Berg Joachim Sieper Siegfrid Wassenberg Gerd Burmester Piet van Riel Maria Diaz-Lorente Gerardus JM Bruin Thasia G Woodworth Christiane Rordorf Yannik Batard Andrew M Wright Thomas Jung 《Arthritis research & therapy》2008,10(3):1-9
Introduction
IL-1β is a proinflammatory cytokine driving joint inflammation as well as systemic signs of inflammation, such as fever and acute phase protein production.Methods
ACZ885, a fully human monoclonal antibody that neutralizes the bioactivity of human IL-1β, was generated to study the potent and long-lasting neutralization of IL-1β in mechanistic animal models as well as in a proof-of-concept study in patients with rheumatoid arthritis (RA).Results
The mouse IL-1 receptor cross-reacts with human IL-1β, and it was demonstrated that ACZ885 can completely suppress IL-1β-mediated joint inflammation and cartilage destruction in mice. This observation prompted us to study the safety, tolerability and pharmacodynamic activity of ACZ885 in RA patients in a small proof-of-concept study – the first to be conducted in humans. Patients with active RA despite treatment with stable doses of methotrexate were enrolled in this dose escalation study. The first 32 patients were split into four cohorts of eight patients each (six were randomly assigned to active treatment and two to placebo). ACZ885 doses were 0.3, 1, 3 and 10 mg/kg, administered intravenously on days 1 and 15. To explore efficacy within 6 weeks of treatment, an additional 21 patients were randomly assigned to the 10 mg/kg cohort, resulting in a total of 20 patients dosed with 10 mg/kg and 15 patients treated with placebo. There was clinical improvement (American College of Rheumatology 20% improvement criteria) at week 6 in the 10 mg/kg treatment group; however, this did not reach statistical significance (P = 0.085). A statistically significant reduction in disease activity score was observed after 4 weeks in the 10 mg/kg group. Onset of action was rapid, because most responders exhibited improvement in their symptoms within the first 3 weeks. C-reactive protein levels decreased in patients treated with ACZ885 within 1 week. ACZ885 was well tolerated. Three patients receiving ACZ885 developed infectious episodes that required treatment. No anti-ACZ885 antibodies were detected during the study.Conclusion
ACZ885 administration to methotrexate-refractory patients resulted in clinical improvement in a subset of patients. Additional studies to characterize efficacy in RA and to determine the optimal dose regimen appear warranted.Trial Registration
ClinicalTrials.gov identifier NCT00619905. 相似文献509.
510.